Literature DB >> 32337600

Is it time for computable evidence synthesis?

Adam G Dunn1,2,3, Florence T Bourgeois3,4.   

Abstract

Efforts aimed at increasing the pace of evidence synthesis have been primarily focused on the use of published articles, but these are a relatively delayed, incomplete, and at times biased source of study results data. Compared to those in bibliographic databases, structured results data available in trial registries may be more timely, complete, and accessible, but these data remain underutilized. Key advantages of using structured results data include the potential to automatically monitor the accumulation of relevant evidence and use it to signal when a systematic review requires updating, as well as to prospectively assign trials to already published reviews. Shifting focus to emerging sources of structured trial data may provide the impetus to build a more proactive and efficient system of continuous evidence surveillance.
© The Author(s) 2020. Published by Oxford University Press on behalf of the American Medical Informatics Association. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Mesh:

Year:  2020        PMID: 32337600      PMCID: PMC7309243          DOI: 10.1093/jamia/ocaa035

Source DB:  PubMed          Journal:  J Am Med Inform Assoc        ISSN: 1067-5027            Impact factor:   4.497


  30 in total

1.  Automating risk of bias assessment for clinical trials.

Authors:  Iain J Marshall; Joël Kuiper; Byron C Wallace
Journal:  IEEE J Biomed Health Inform       Date:  2015-05-08       Impact factor: 5.772

2.  A Global, Neutral Platform for Sharing Trial Data.

Authors:  Barbara E Bierer; Rebecca Li; Mark Barnes; Ida Sim
Journal:  N Engl J Med       Date:  2016-05-11       Impact factor: 91.245

3.  Mass Production of Systematic Reviews and Meta-analyses: An Exercise in Mega-silliness?

Authors:  Matthew J Page; David Moher
Journal:  Milbank Q       Date:  2016-09       Impact factor: 4.911

4.  Learning from hackers: open-source clinical trials.

Authors:  Adam G Dunn; Richard O Day; Kenneth D Mandl; Enrico Coiera
Journal:  Sci Transl Med       Date:  2012-05-02       Impact factor: 17.956

5.  Evaluating adherence to the International Committee of Medical Journal Editors' policy of mandatory, timely clinical trial registration.

Authors:  Vojtech Huser; James J Cimino
Journal:  J Am Med Inform Assoc       Date:  2013-02-09       Impact factor: 4.497

6.  A shared latent space matrix factorisation method for recommending new trial evidence for systematic review updates.

Authors:  Didi Surian; Adam G Dunn; Liat Orenstein; Rabia Bashir; Enrico Coiera; Florence T Bourgeois
Journal:  J Biomed Inform       Date:  2018-02-02       Impact factor: 6.317

7.  Beyond trial registration: a global trial bank for clinical trial reporting.

Authors:  Ida Sim; Don E Detmer
Journal:  PLoS Med       Date:  2005-10-18       Impact factor: 11.069

8.  Trial2rev: Combining machine learning and crowd-sourcing to create a shared space for updating systematic reviews.

Authors:  Paige Martin; Didi Surian; Rabia Bashir; Florence T Bourgeois; Adam G Dunn
Journal:  JAMIA Open       Date:  2019-01-11

9.  Comparison of serious adverse events posted at ClinicalTrials.gov and published in corresponding journal articles.

Authors:  Eve Tang; Philippe Ravaud; Carolina Riveros; Elodie Perrodeau; Agnes Dechartres
Journal:  BMC Med       Date:  2015-08-14       Impact factor: 8.775

10.  Linking ClinicalTrials.gov and PubMed to track results of interventional human clinical trials.

Authors:  Vojtech Huser; James J Cimino
Journal:  PLoS One       Date:  2013-07-09       Impact factor: 3.240

View more
  3 in total

1.  Reporting of clinical trial safety results in ClinicalTrials.gov for FDA-approved drugs: A cross-sectional analysis.

Authors:  Krista Y Chen; Erin M Borglund; Emma Charlotte Postema; Adam G Dunn; Florence T Bourgeois
Journal:  Clin Trials       Date:  2022-04-28       Impact factor: 2.599

2.  It is time for computable evidence synthesis: The COVID-19 Knowledge Accelerator initiative.

Authors:  Brian S Alper; Joshua E Richardson; Harold P Lehmann; Vignesh Subbian
Journal:  J Am Med Inform Assoc       Date:  2020-08-01       Impact factor: 4.497

Review 3.  Challenges of evidence synthesis during the 2020 COVID pandemic: a scoping review.

Authors:  Hanan Khalil; Lotfi Tamara; Gabriel Rada; Elie A Akl
Journal:  J Clin Epidemiol       Date:  2021-10-27       Impact factor: 6.437

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.